(In)Fertility in the Down syndrome

Down syndrome (DS) is the most frequent genetic cause of intellectual disability, and it occurs in approximately 1 of 800 births worldwide. The causes of DS include trisomy (95%), translocation (3–4%), mosaicism (1–2%), and partial trisomy (<1%)¹. A recent review described genes that may play causal roles in DS phenotypes such as gene expression changes affecting brain development, cardiac tissues, and ocular development, which lead to myeloproliferative disease and endocrine diseases².

A Brazilian study reported that DS was associated with maternal age ≥ 35 years, paternal age ≥ 30 years, the performance of six or more prenatal consultations, prematurity, and low birth weight (p<0.05)³. It is consensus in the scientific literature that the main established risk factor associated with DS is still advanced maternal age (≥ 35 years)⁴.

The average life expectancy for people with DS has substantially increased from 25 years in 1983 to 60 years in 2020 due to improvements in medical care. This way a clinical guideline with recommendations to support high-quality primary care for adults with DS is essential⁵. A systematic review highlighted the need to improve the quality of life in adults with DS. Most of them wanted to become more independent, have relationships, participate in the community, and exercise their human rights⁶.

Furthermore, because individuals with DS are living longer, the question of (in)fertility must also be considered.

The literature data suggest that fertility is impaired in people with DS. This genetic condition appears to cause spermatogenesis defects in men and premature menopause in women. Nevertheless, some people with DS have become parents, and others are seeking to have children. In these cases, one must consider the person’s ability to care for and educate a child and the rationale for access to assisted reproductive technology (ART) and/or oocyte donation programs. DS is associated with early dementia (early-onset Alzheimer’s disease, i.e., at around the age of 40 years) which significantly impairs personal independence and parenting abilities⁷.

In addition, the risk of transmission of DS differs dramatically for men vs. women with DS. According to the literature data, all the children fathered by a man with DS (with or without ART) have been healthy. In contrast, one out of three children born to a woman with DS themselves have DS. In summary, the intellectual disability, early dementia, and the transmission of the pathology to their offspring have a negative influence on parenting in the DS⁷.

Often men with DS are infertile. Until 2019, only three cases of spontaneous conception in men with DS have been described⁷. One of them is a case report published in 2006 that described a 26-year-old man with DS fathered a normal son and the paternity was proven by microsatellite marker analysis⁸. Another case report more recently reported that a 36-year-old man with 47,XY,+21 karyotype is the biological father of his two normal boys, and paternity analysis using 26 microsatellite loci confirmed this result⁹. These studies support the necessity of advising people responsible for the care of adults with DS about possible fertility.

Alnoman et al.¹⁰ utilized a population database to address the paucity of data around pregnancy outcomes in women with DS. Patients with DS were at increased risk of giving birth prematurely (aOR 3.09, 95%CI 2.06–4.62) and having adverse neonatal outcomes such as small for gestational age (aOR 2.70, 95%CI 1.54–4.73), intrauterine fetal demise (aOR 22.45, 95%CI 12.02–41.93), congenital anomalies (aOR 7.92, 95%CI 4.11–15.24), and fetal chromosomal abnormalities. Women with DS should be counseled preconceptionally about these risks, and increased antenatal surveillance is advised¹⁰.

The data presented here reinforce the importance of providing guidance to health professionals on fertility in DS, despite the fact that evidence of these individuals having descendants is rare. There is a paucity of data in the literature about (in)fertility in the DS, highlighting the need for more studies in this area.

REFERENCES

• ^1.
  Bull MJ. Down syndrome. N Engl J Med. 2020;382(24):2344-52. https://doi.org/10.1056/NEJMra1706537
  » https://doi.org/10.1056/NEJMra1706537
• ^2.
  Chapman LR, Ramnarine IVP, Zemke D, Majid A, Bell SM. Gene expression studies in Down syndrome: what do they tell us about disease phenotypes? Int J Mol Sci. 2024;25(5):2968. https://doi.org/10.3390/ijms25052968
  » https://doi.org/10.3390/ijms25052968
• ^3.
  Laignier MR, Lopes-Júnior LC, Santana RE, Leite FMC, Brancato CL. Down syndrome in Brazil: occurrence and associated factors. Int J Environ Res Public Health. 2021;18(22):11954. https://doi.org/10.3390/ijerph182211954
  » https://doi.org/10.3390/ijerph182211954
• ^4.
  Blanco-Montaño A, Ramos-Arenas M, Yerena-Echevarría BA, Miranda-Santizo LD, Ríos-Celis AL, Dorantes-Gómez AT, et al. Factores de riesgo en el origen del síndrome de Down [Risk factors in the origin of Down syndrome]. Rev Med Inst Mex Seguro Soc. 2023;61(5):638-44. https://doi.org/10.5281/zenodo.8316459
  » https://doi.org/10.5281/zenodo.8316459
• ^5.
  Tsou AY, Bulova P, Capone G, Chicoine B, Gelaro B, Harville TO, et al. Medical care of adults with Down syndrome: a clinical guideline. JAMA. 2020;324(15):1543-56. https://doi.org/10.1001/jama.2020.17024
  » https://doi.org/10.1001/jama.2020.17024
• ^6.
  Ijezie OA, Healy J, Davies P, Balaguer-Ballester E, Heaslip V. Quality of life in adults with Down syndrome: a mixed methods systematic review. PLoS One. 2023;18(5):e0280014. https://doi.org/10.1371/journal.pone.0280014
  » https://doi.org/10.1371/journal.pone.0280014
• ^7.
  Parizot E, Dard R, Janel N, Vialard F. Down syndrome and infertility: what support should we provide? J Assist Reprod Genet. 2019;36(6):1063-7. https://doi.org/10.1007/s10815-019-01457-2
  » https://doi.org/10.1007/s10815-019-01457-2
• ^8.
  Pradhan M, Dalal A, Khan F, Agrawal S. Fertility in men with Down syndrome: a case report. Fertil Steril. 2006;86(6):1765.e1-3. https://doi.org/10.1016/j.fertnstert.2006.03.071
  » https://doi.org/10.1016/j.fertnstert.2006.03.071
• ^9.
  Jazayeri O, Gorjizadeh N. A male Down syndrome with two normal boys: cytogenetic, paternity and andrological investigations. Andrologia. 2020;52(3):e13521. https://doi.org/10.1111/and.13521
  » https://doi.org/10.1111/and.13521
• ^10.
  Alnoman A, Baghlaf HA, Badeghiesh AM, Peeva M, Dahan MH. Pregnancy, delivery, and neonatal outcomes among women living with Down syndrome: a matched cohort study, utilizing a population database. Arch Gynecol Obstet. 2024;309(6):2681-7. https://doi.org/10.1007/s00404-023-07208-0
  » https://doi.org/10.1007/s00404-023-07208-0

• Funding:

  none.

Publication Dates

• Publication in this collection
  30 Aug 2024
• Date of issue
  2024

History

• Received
  11 Apr 2024
• Accepted
  29 May 2024